Macular Degeneration Treatment Market Will Exceed $21.1 Billion By 2031: TMR Study

  • The massive need for effective treatments for wet age-related macular degeneration presents a tremendous opportunity to leverage the value of companies in the macular degeneration treatment market; growing adoption of anti-VEGF drugs for age-related macular degeneration (AMD) drives revenue generation
  • Europe market to expand at a promising pace, spurred by new product launches; huge demand for treatment in hospitals, especially in the elderly

WILMINGTON, Del., September 21, 2022 /PRNewswire/ — Increasing demand for wet age-related macular degeneration treatments has driven significant revenue streams in the market over the years. The segment was the largest revenue generator in macular degeneration treatment market in 2021, and is projected to expand rapidly during the forecast period. The growing burden of retinal disorders has stimulated demand for products in the macular degeneration treatment market. The size of the total market is estimated to exceed $21.1 billion by 2031.

Get Exclusive PDF Sample Copy of Macular Degeneration Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60645

Recent developments in the macular degeneration treatment market underscore that key players are leaning on longer-acting anti-VEGF development to capture significant revenue share. The high burden of age-related macular degeneration (AMD), revolving around rapidly aging populations in industrialized countries, underpins enormous earning potential.

Increasing awareness of the efficacy of intravitreal injections (IVTs) for wet AMD has driven revenue generation in the macular degeneration treatment market. Many leading players in the macular degeneration treatment market are actively involved in increasing the safety and efficacy of antivascular endothelial growth factor-based therapies. R&D on vascular endothelial growth factor (VEGF) will create lucrative future market demand for the treatment of macular degeneration.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=60645

Key Findings of the Macular Degeneration Treatment Market Study

  • Abundant demand for therapies for the management of wet age-related macular degeneration: Massive demand for therapies for wet age-related macular degeneration (exudative or neovascular) is driving market growth. Wet AMD is one of the leading causes of visual impairments in the elderly and thus has a wide pathway. The increase in the number of injections approved by the FDA has strengthened the growth prospects of the macular degeneration treatment market. Wet AMD presents the fastest growing market for the treatment of macular degeneration. Meanwhile, the study authors found that adoption of age-related macular degeneration (AMD) treatments supports huge revenue streams. Players are launching novel drugs to gain a competitive advantage over others.
  • Mass demand for treatment in hospital settings: Developed countries are witnessing a high prevalence of AMD. Notably, the diagnosis of new cases of AMD in hospitals has driven the need for macular degeneration treatments. The hospital segment is expected to account for the majority of the share by the end of 2031.

Macular Degeneration Treatment Market: Key Factors

  • The growing awareness of the prevalence and burden of age-related macular degeneration, especially in developed countries, is a key driver of the macular degeneration treatment market. In patients over the age of 60, AMD is one of the most common causes of vision loss and visual impairment.
  • Increasing R&D on vascular endothelial growth factor (VEGF) has aided in the development of more effective therapies, thus broadening the avenues in the macular degeneration treatment market. The increasing prevalence of retinal disorders with age is a key trend presenting untapped revenue potential for market players.

Make an inquiry before buyinghttps://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60645

Macular Degeneration Treatment Market: Regional Growth Dynamics

  • North America held a significant share of the global macular degeneration treatment market in 2021. The substantial adoption rate of products in the US has led to significant lucrative opportunities. Additionally, the increase in product launches in the US has also bolstered revenue streams.
  • Europe it holds a key market share in 2021 and is anticipated to expand at a rapid rate during the forecast period of 2022-2031. Widespread demand for brand-name drugs and the introduction of new macular degeneration drugs are strengthening the growth prospects for the Europe macular degeneration treatment market.
  • Pacific Asia it is a lucrative region in the macular degeneration treatment market. The increasing diagnosis of AMD has catalyzed the need for treatment.

Macular Degeneration Treatment Market: Competition Landscape

The presence of several major players vying for a significant share of the global market makes the competitive landscape highly fragmented. Some of the key players are Santen Pharmaceutical Co., Ltd., Novartis AG, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Pfizer, Inc., and AbbVie, Inc.

Segmentation of the macular degeneration treatment market

  • disease indication
    • Wet age-related macular degeneration
    • dry age-related macular degeneration
    • Others
  • drug class
    • Antivascular Endothelial Growth Factor
    • Others
  • Distribution channel
    • hospitals
    • Ophthalmology Clinics
    • Ambulatory Surgical Centers

Region

  • North America
  • Latin America
  • Europe
  • Pacific Asia
  • middle East & Africa

The modernization of healthcare in terms of infrastructure and services has taken the healthcare industry to new heights. Stay up to date with More recent Healthcare Research Reports by Transparency Market Research:

Skin care serum market: The global market for skin care serums is anticipated to reach more than $6.28 billion by the end of 2031 with a CAGR of 7.4% from 2022 to 2031.

Epilepsy Therapeutic Market: The global market for epilepsy therapies is anticipated to reach more than $14.9 billion at the end of 2031.

Vitamin D testing market: The global market for vitamin D tests is projected to reach more than $1.06 billion at the end of 2031 with a CAGR of 5.8% from 2022 to 2031.

Laboratory Gas Generator Market: The global market for laboratory gas generators is expected to reach more than $1.27 billion by the end of 2031 with a CAGR of 11.0% from 2022 to 2031.

Bruise Treatment Market: The global hematoma treatment market is anticipated to reach more than $444Mn by the end of 2031 with a CAGR of 3.5% from 2022 to 2031.

Substance Abuse Treatment Marketplace: The global substance abuse treatment market is anticipated to cross $23.1 billion by 2031 with a CAGR of 8.5% from 2022 to 2031.

Chronic Pelvic Pain Treatment Market: The global chronic pelvic pain treatment market is anticipated to reach more than $8 billion by the end of 2031 with a CAGR of 3.6% from 2022 to 2031.

Psoriasis Treatment Market: The global psoriasis treatment market is projected to reach more than $44 billion by the end of 2031 with a CAGR of 8.7% from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered in Wilmington, Del., USAprovides personalized research and consulting services. Our unique combination of quantitative forecasting and trend analysis provides forward-looking information for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to collect and analyze information.

Our data repository is continually updated and revised by a team of research experts, so it always reflects the latest trends and information. With extensive research and analytical capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

For more research information on leading industries, please visit our YouTube channel and click subscribe for future updates. https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact
Rohit Bhissey
Transparency Market Research Inc.
CENTER CORPORATE HEADQUARTERS,
1000 N. West Street,
suite 1200, Wilmington, Del. 19801 United States
Phone: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

SOURCE Transparency Market research

Leave a Reply

Your email address will not be published.